Back to results
US 9,346,829 B2Granted
5-HT3 receptor antagonists
AssigneeTakeda Phamaceutical Company Limited
InventorsStephen Hitchcock, Holger Monenschein, Holly Reichard, Huikai Sun, Shota Kikuchi, Todd Macklin, Maria Hopkins
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treating nicotine addiction comprising administering a 5-HT3 receptor antagonists of Formula (I):
Claims2
A method of treating a nicotine addiction comprising:
- administrating to a patient in need thereof a therapeutically effective amount of a compound of the formula
- wherein:
- Z is O or NRa where Ra is hydrogen or C1-6 alkyl;
- R1 is a ring of the formula (a)-(h) below:
- R2 is hydrogen, C1-6 alkyl, or C1-6 haloalkyl;
- each R3 is independently hydrogen, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkoxy, or halo and can be present on any carbon atom in the rings;
- R4 is pyridinyl or pyrazolyl each optionally substituted with one or two substituents independently selected from C1-6 alkyl, C1-6 haloalkyl, C1-6 haloalkoxy, C1-6 alkoxy, cyano, or halo;
- all of X1, X2, X3, and X4 are CR5;
- each R5 is independently hydrogen, C1-6 alkyl, halo, hydroxy, or cyano provided that at least one of R5 is hydrogen;
- X5 is CR6 where R6 is hydrogen, C1-6 alkyl, or halo;
- or a pharmaceutically acceptable salt thereof or N-oxide thereof.
8 more elements
Dependencies are inferred from the claim text.